Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Nippon Indosari Corpindo Tbk. (ROTI) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Nippon Indosari Corpindo Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Nippon Indosari Corpindo Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Nippon Indosari Corpindo Tbk. trades at Rp605 (market cap 3.77T, 183.8K 24h volume). The key difference: Nippon Indosari Corpindo Tbk. is far larger — about 12.1× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 183.8K). Which is the better fit depends on your goals.

DGNSROTI
Market Cap
310.75B3.77T
Volume
963.6K183.8K
Lot
9.64K1.84K
Turnover
217.67M111.59M
Average Price
225.89607.13
Value
217.67M111.59M
Indicative Equilibrium Price
226605
Indicative Equilibrium Volume
1K330

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
ROTI
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Nippon Indosari Corpindo Tbk.

PT Nippon Indosari Corpindo (the company) was established under its original name of PT Nippon Indosari Corporation base on notarial deed No.11 of Benny Kristianto, S.H, dated on Mar 8, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 71 of Isbandi, S.H., dated Feb 24, 2010, concerning among others, the change in the Company’s name, and public offering.

Read more on ROTI